(3-Bromo-2-ethoxy-5-fluorophenyl)boronic acid, 95%, 5g

4-Methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 98%, 100mg

(2R,3S,4S,5R)-2-(Acetoxymethyl)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate, 95%, 100mg

(R)-5-(Chloromethyl)oxazolidin-2-one, 98%, 5g

3-Phenylpyridine>94.0%(GC)25g

Dicyclohexyl(2',6'-dimethoxy-[1,1'-biphenyl]-2-yl)phosphine, 98.0%, 25g

(E)-2-(4-Fluorostyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

4-ethoxycarbonyl-3'-nitrobenzophenone, 97.0%, 1g

Provette per centrifuga con fondo rotondo, 16 ml, 500 Pezzo(i)

1-Chloro-2-(trifluoromethyl)-4-(4-vinylphenoxy)benzene, 250mg

Ethyl 2-bromooxazole-5-carboxylate, 95.0%, 100mg

N-(2-N-Boc-Amino-acetyl)-glycine, 97.00%, 5g

4-Hydroxy-2-(pyridin-2-yl)pyrimidine-5-carboxylic acid, 95.0%, 250mg